Breakloop is a distributed drug-discovery lab & development partner. We collaborate on novel molecules for clinical development, as well as formulations and manufacturing methods of natural molecules for the nutraceutical market.
❤️🩹 Long-COVID, CFS/ME, TBI & CTE, multiple sclerosis, ALS, fibromyalgia, concussion/whiplash & PCS, MCAS/MCS, pulmonary fibrosis, mold illness, asthma, arthritis, IBD, migraine, hearing loss & tinnitus, opioid & benzo dependence, epilepsy, ADHD, anxiety, depression, inflammaging & longevity...
🔍 Feedback loops in excitotoxicity and E:I balance, immune homeostasis, synaptogenesis, mitochondrial function, stem-cell regulation, C/A-fibre sensitivity, HPA/SNS control, circadian rhythm, aversion/reward processing...
We like pharmacology and chemistry. We don't like chronic illness. And we don't like medicines that make people sicker.
Company Details
- Employees
- 4
- Founded
- 2023
- Address
- Nyc, Ny 10013, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- NYC, NY
Breakloop Bio Questions
Breakloop Bio's LinkedIn profile is https://www.linkedin.com/company/breakloop
Breakloop Bio has
4 employees.
View email and phone details for 4
employees at Breakloop Bio.
Breakloop Bio's industry is
Biotechnology Research
Breakloop Bio's top competitors are
Promafun Crio,
Cryoduck B.v.,
Enigma Therapeutics,
D2team,
Purex Laboratories (I) Private Limited,
Skven Technologies Pvt. Ltd.,
Sgt - Skill Development Hub,
Pyxis Discovery,
Salve,
Inntrest Consultancy Bv.
Breakloop Bio's categories are Biotechnology Research
Breakloop Bio's founding year is 2023
